Proteinases in Naegleria Fowleri (strain NF3), a pathogenic amoeba: a preliminary study

Nakisah Mat Amin1

  • 1Department of Biological Sciences, Faculty of Sciences and Technology, Kolej Universiti Sains dan Teknologi Malaysia [KUSTEM], Mengabang Telipot, 21030 Kuala Terengganu, Terengganu, Malaysia.

Tropical Biomedicine
|February 24, 2006
PubMed

Insights

This study identified two high molecular weight proteinases in Naegleria fowleri, a pathogen causing Primary amoebic meningoencephalitis (PAM). These enzymes, particularly a cysteine proteinase, may contribute to the amoeba's virulence.

Area of Science:

  • Microbiology
  • Biochemistry

Background:

  • Naegleria fowleri causes Primary amoebic meningoencephalitis (PAM), a fatal CNS disease.
  • Pathogenicity factors are known, but proteinase roles remain uninvestigated.
  • Entamoeba histolytica virulence involves a cysteine proteinase.

Purpose of the Study:

  • To investigate the presence and characteristics of proteinases in Naegleria fowleri.
  • To determine if proteinases contribute to the pathogenicity of Naegleria fowleri.

Main Methods:

  • Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using gelatin zymography.
  • Analysis of enzyme activity at different pH levels and in the presence of DTT.
  • Enzyme inhibition assays using E-64 and antipain.

Main Results:

  • Two high molecular weight proteinases (approx. 128 kDa and 170 kDa) were detected in Naegleria fowleri.
  • The 128 kDa proteinase is membrane-associated, with optimal activity at alkaline pH and DTT stimulation at lower pH.
  • The 170 kDa proteinase shows higher activity at lower pH, is DTT-dependent, and is inhibited by E-64 and antipain, suggesting it is a cysteine proteinase.

Conclusions:

  • Naegleria fowleri possesses at least two distinct high molecular weight proteinases.
  • The identified cysteine proteinase may play a significant role in the virulence of Naegleria fowleri.
  • Further research into these proteinases could reveal new therapeutic targets for PAM.